Oculis Holding AG (OCS) Market Cap to FCF (2021 - 2026)

Oculis Holding AG (OCS) Market Cap to FCF (2021 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Market Cap to FCF
1	Oculis Holding AG	66,140.12 Bn	66,139.83 Bn	-	-851,301.90
2	Nanobiotix	1,933.82 Bn	1,933.76 Bn	-	-49,404.47
3	Akari Therapeutics	1,022.34 Bn	1,022.34 Bn	-	-93,741.38
4	BeOne Medicines	472.04 Bn	467.25 Bn	1.35 Bn	379.36
5	Vertex Pharmaceuticals	122.28 Bn	115.03 Bn	2.59 Bn	32.96
6	Regeneron Pharmaceuticals	70.07 Bn	61.31 Bn	3.31 Bn	17.04
7	Belite Bio	62.66 Bn	62.66 Bn	-	-6,034.09
8	Argenx Se	56.16 Bn	50.98 Bn	1.41 Bn	-
9	Alnylam Pharmaceuticals	37.56 Bn	34.55 Bn	959.66 Mn	58.38
10	Revolution Medicines	37.43 Bn	37.43 Bn	-	-34.93

Download Data